Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal
Молекулярная медицина, 2026, № 3

Molecular Medicine

Current issue

2026, No. 3

Published materials: 15. Sections: ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ; ОБЗОР.
Volume
24
Article page range
3–116

See the journal’s author guidelines for manuscript submission and formatting requirements.

Submit an article

Table of contents

ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ

ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ2026 · pp. 3–8

Molecular mechanisms of astrocyte involvement in the pathogenesis of Parkinson’s disease

Introduction. Parkinson’s disease (PD) is a chronic, progressive neurodegenerative disorder, the primary pathological feature of which is the death of dopaminergic neurons in the substantia nigra pars compacta and the accumulation of aggregated α-synuclein. Th…

10.29296/24999490-2026-03-01Details ↗
ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ2026 · pp. 9–14

Age-related changes in 5xFAD microglia

Introduction. Microglia initiate and play a key role in neuroinflammation, which is currently considered one of the main mechanisms of neurodegeneration in Alzheimer’s disease. The aim of this study was to analyze the morphofunctional characteristics of microg…

10.29296/24999490-2026-03-02Details ↗
ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ2026 · pp. 15–23

Molecular heterogeneity of obesity: psychobiological mechanisms, limitations of the diagnostic model, and prospects for the development of personalized diagnosis and treatment

Introduction. Obesity can no longer be adequately described by body mass index alone. Similar BMI values may coexist with different fat distribution, inflammatory burden, neuroendocrine dysregulation, psychobehavioral traits, and risks of organ dysfunction. Ob…

10.29296/24999490-2026-03-03Details ↗
ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ2026 · pp. 24–33

Transcription factors bioinformatic analysis of differential gene expression in b16 melanoma cells under antitumor alkylating agent application

Introduction. Cancer drug resistance is driven among others, by non-genetic mechanisms. These processes may involve transcription factors dysregulation, modifications in gene expression, as well as epigenetic mechanisms such as DNA methylation, histone modific…

10.29296/24999490-2026-03-04Details ↗
ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ2026 · pp. 34–43

Low-intensity inflammation and pleiotropic effect of delayed-action drugs (SYSADOA) in comorbid patients with primary open-angle glaucoma and osteoarthritis

Introduction. Primary open-angle glaucoma is considered a multifactorial disease, in the pathogenesis of which low-grade inflammation, cytokine imbalance, extracellular matrix remodeling, and neuroinflammation play a significant role. In comorbid patients with…

10.29296/24999490-2026-03-05Details ↗
ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ2026 · pp. 44–56

Molecular mechanisms of the cardiometabolic phenotype in arterial hypertension and obesity in women: from endothelial dysfunction to personalized risk stratification

Introduction. Arterial hypertension (AH) and obesity form a common cardiometabolic phenotype, in which hemodynamic overload, dysfunctional adipose tissue, estrogen deficiency, dyslipidemia, endothelial dysfunction, vascular remodeling, and electrophysiological…

10.29296/24999490-2026-03-06Details ↗
ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ2026 · pp. 53–58

Modern anticoagulants in the treatment and prevention of thrombotic complications in patients with Hodgkin’s lymphoma

Introduction. Cancer patients have a high risk of developing venous thromboembolic complications, which worsen the outcomes of antitumor treatment and are the second leading cause of death after cancer progression. Objectives – to assess the effect of modern a…

10.29296/24999490-2026-03-07Details ↗

ОБЗОР

ОБЗОР2026 · pp. 59–66

Molecular and biological characteristics of tumor cells in testicular embryonal carcinoma explants

Introduction. Personalized treatment strategies for embryonal carcinoma, a germ cell tumor, are crucial due to the inherent heterogeneity of the tumor. Existing in vitro models inadequately reflect the native tumor microenvironment. Ex vivo organ culture (EVOC…

10.29296/24999490-2026-03-08Details ↗
ОБЗОР2026 · pp. 73–78

Molecular genetic aspects of the pathogenesis of pain syndrome in multiple myeloma

Introduction. This review is devoted to the problem of the pathogenesis of pain syndrome in multiple myeloma (MM). The severity of pain often correlates poorly with the plasma cell burden but is highly dependent on tumor aggressiveness determined by primary ge…

10.29296/24999490-2026-03-10Details ↗
ОБЗОР2026 · pp. 79–86

Molecular mechanisms, pharmacological properties, and applications of PARP inhibitors in ovarian cancer therapy

Relevance. PARP inhibitors (PARPi), have emerged as a significant development in the treatment of high-grade serous ovarian cancer that is associated with mutations in BRCA1/2 and genes of other homologous recombination proteins. These drugs exploit synthetic …

10.29296/24999490-2026-03-11Details ↗
ОБЗОР2026 · pp. 93–99

Molecular and cellular characteristics of aortic aneurysm at different stages of its development

Introduction. An aortic aneurysm is defined as an irreversible progressive enlargement of the aorta with an increasing risk of rupture, often fatal. It is known that the imbalance of inhibitors and activators of cell matrix proteolysis and the death of smooth …

10.29296/24999490-2026-03-13Details ↗
ОБЗОР2026 · pp. 100–106

Molecular predictors of efficacy of single-stranded yeast RNA and ascorbic acid complexes: from critical quality attributes to personalized immunomodulation

Introduction. Single-stranded yeast RNA–ascorbic acid complexes are of interest as a class of natural immunomodulatory systems combining activation of innate immune pattern-recognition receptors with redox-modulating and epigenetic effects of vitamin C. Russia…

10.29296/24999490-2026-03-14Details ↗
ОБЗОР2026 · pp. 107–116

Genetic architecture and molecular mechanisms of cerebrovascular diseases: ischemic stroke, cerebral small vessel disease and intracranial aneurysms in the context of personalized medicine

Introduction. Cerebrovascular diseases are a heterogeneous group of conditions shaped by the interaction of polygenic susceptibility, rare monogenic variants, vascular remodeling, neuroinflammation, dysregulated hemostasis, and epigenetic reprogramming. Recent…

10.29296/24999490-2026-03-15Details ↗

Article search and quick navigation

Navigation